# The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision

> **NCT05978687** · PHASE4 · COMPLETED · sponsor: **Vrije Universiteit Brussel** · enrollment: 41 (actual)

## Conditions studied

- Pterygium

## Interventions

- **DRUG:** OPHTESIC LIDOCAINE HYDROCHLORIDE 20MG/G
- **DRUG:** Xylocaine with Epinephrine

## Key facts

- **NCT ID:** NCT05978687
- **Lead sponsor:** Vrije Universiteit Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978687, "The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05978687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*